MIST logo

MIST

Profile

Full Name

Milestone Pharmaceuticals Inc.

Ticker Symbol

MIST

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

May 9, 2019

Indexes

Not included

Website

http://www.milestonepharma.com

Employees

33

Key Details

Price

$0.83(+7.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.67(+51.80% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.83
MIST price is $0.83

30-Day Relative Volume

0.30
MIST 30-day relative volume is 0.30

Price Performance

Price Today change

+7.86%
MIST price is up +7.86% today

Price YTD change

-64.76%
MIST price is down -64.76% since January 1st

Price 1-year change

-51.93%
MIST price is down -51.93% year-on-year

Price 3-year change

-88.72%
MIST price is down -88.72% over the past 3 years

Price Range

Price All-time high

$27.95
MIST price is currently -97.02% below its historical high of $27.95

Price 3-year low

$0.63
MIST price is currently +33.06% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$44.37M
MIST market capitalization is $44.37 million

Market cap 3-year change

-79.88%
MIST market capitalization is down -79.88% over the past 3 years

Market cap All-time high

$664.92M
MIST market capitalization is currently -93.33% below its historical high of $664.92 million

Market cap sector rank

36.48%
MIST market capitalization is higher than 36.48% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.2%
MIST shares outstanding is up +0.2% year-on-year

Shares Outstanding 3-Year Change

+78.34%
MIST shares outstanding is up +78.34% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.28
MIST beta is 1.28

200-day SMA

$1.66
MIST price is currently -49.95% below its 200-day simple moving average

50-day SMA

$1.71
MIST price is currently -51.42% below its 50-day simple moving average

RSI

35.37
MIST 14-day relative strength index is 35.37

Volume

0.30
MIST 30-day relative volume is 0.30

ATR

$0.17
MIST average true range is $0.17

10-day Historical Volatility

100.96%
MIST 10-day historical volatility is 100.96%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
MIST annual revenue value is unknown

Revenue Analysts estimate

-
MIST annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
MIST annual revenue 1-year change is unknown

Revenue Sector rank

-
MIST annual revenue is unknown

EPS

EPS

-$0.67
MIST annual earnings per share is -$0.67

EPS Analysts estimate

-$1.29
MIST annual earnings per share is currently -48.26% lower than the consensus analysts' forecast

EPS 1-year change

+51.8%
MIST annual earnings per share is up +51.8% year-on-year

EPS Sector rank

64.08%
MIST annual earnings per share is higher than 64.08% of companies in Healthcare sector

Profit

Gross profit

-
MIST annual gross profit value is unknown

Gross margin

-
MIST annual gross profit margin value is unknown

Operating profit

-$42.10M
MIST annual operating income is -$42.10 million

Operating margin

-
MIST annual operating profit margin value is unknown

Net income

-$41.52M
MIST annual net profit is -$41.52 million

Net margin

-
MIST annual net profit margin value is unknown

Expenses

Total expenses

$42.10M
MIST annual total expenses is $42.10 million

Operating expenses

$42.10M
MIST annual total operating expenses is $42.10 million

Cost of goods sold

-
MIST annual cost of goods sold value is unknown

Selling, general & administrative expenses

$27.75M
MIST annual SGA is $27.75 million

Depreciation and amortization

$105.00K
MIST annual depreciation & amortization is $105.00 thousand

Interest expense

$3.58M
MIST annual interest expense is $3.58 million

Income tax

-
MIST annual income tax value is unknown

EBIT & EBITDA

EBIT

-$37.94M
MIST annual earnings before interest & taxes is -$37.94 million

EBITDA

-$37.83M
MIST annual EBITDA is -$37.83 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$75.50M
MIST annual total assets is $75.50 million

Non current assets

$1.57M
MIST annual long term assets is $1.57 million

Current assets

$73.93M
MIST annual total current assets is $73.93 million

Cash and cash equivalents

$25.31M
MIST annual cash & cash equivalents is $25.31 million

Accounts receivable

-
MIST annual accounts receivable value is unknown

Inventory

-
MIST annual inventory value is unknown

Liabilities

Total liabilities

$62.35M
MIST annual total liabilities is $62.35 million

Long term liabilities

$54.23M
MIST annual total long term liabilities is $54.23 million

Current liabilities

$8.13M
MIST annual total current liabilities is $8.13 million

Accounts payable

$1.93M
MIST annual accounts payable is $1.93 million

Debt

Total debt

$54.80M
MIST annual total debt is $54.80 million

Total debt 1-year change

+5.84%
MIST annual total debt is up +5.84% year-on-year

Long term debt

$54.23M
MIST annual long term debt is $54.23 million

Short term debt

$571.00K
MIST annual short term debt is $571.00 thousand

Equity & Capital

Shareholders equity

$13.15M
MIST annual stockholders equity is $13.15 million

Book value

$13.15M
MIST annual book value is $13.15 million

Retained earnings

-$367.55M
MIST annual retained earnings is -$367.55 million

Working capital

$65.80M
MIST annual working capital is $65.80 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$28.85M
MIST annual cash flow from operations is -$28.85 million

Cash from operations 1-year change

+37.86%
MIST annual cash flow from operations is up +37.86% year-on-year

Cash from investing

$8.28M
MIST annual cash flow from investing activities is $8.28 million

Cash from investing 1-year change

+74.16%
MIST annual cash flow from investing activities is up +74.16% year-on-year

Cash from financing

$32.12M
MIST annual cash flow from financing activities is $32.12 million

Cash from financing 1-year change

-32.79%
MIST annual cash flow from financing activities is down -32.79% year-on-year

CAPEX

CAPEX

-
MIST annual capital expenditures value is unknown

CAPEX 1-year change

-
MIST annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$28.88M
MIST annual free cash flow is -$28.88 million

Free cash flow 1-year change

+37.94%
MIST annual free cash flow is up +37.94% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MIST annual gross profit margin value is unknown

Operating margin

-
MIST annual operating profit margin value is unknown

Net margin

-
MIST annual net profit margin value is unknown

ROA & ROE

ROA

-54.99%
MIST annual return on assets is -54.99%

ROE

-315.81%
MIST annual return on equity is -315.81%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MIST price to earnings ratio value is unknown

PE ratio Sector rank

-
MIST price to earnings ratio is unknown

PB Ratio

PB ratio

3.37
MIST price to book ratio is 3.37

PB ratio Sector rank

74.26%
MIST price to book ratio is higher than 74.26% of companies in Healthcare sector

PS Ratio

PS ratio

-
MIST price to sales ratio value is unknown

PS ratio Sector rank

-
MIST price to sales ratio is unknown

Enterprise value

Enterprise value

$73.85M
MIST enterprise value is $73.85 million

Enterprise value Sector rank

45.83%
MIST enterprise value is higher than 45.83% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.95
MIST EV/EBITDA is -1.95

EV/EBITDA Sector rank

32.15%
MIST EV/EBITDA is higher than 32.15% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.10
MIST annual current ratio is 9.10

Quick ratio

-
MIST annual quick ratio value is unknown

Leverage

Debt to equity

4.17
MIST annual debt to equity ratio is 4.17

Interest coverage ratio

-10.59
MIST annual interest coverage ratio is -10.59

Risk & Stability

Piotroski F-Score

-
MIST piotroski f-score value is unknown

Altman Z-Score

-
MIST altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 1, 25 HC Wainwright & Co.
Buy
Mar 28, 25 HC Wainwright & Co.
Buy
Mar 17, 25 HC Wainwright & Co.
Buy
Feb 28, 25 HC Wainwright & Co.
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Oct 14, 24 HC Wainwright & Co.
Buy
Aug 22, 24 Rodman & Renshaw
Buy
Aug 22, 24 HC Wainwright & Co.
Buy
Jul 1, 24 HC Wainwright & Co.
Buy
May 30, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

IPSC logo
Century Therapeutics (IPSC)
ATNM logo
Actinium Pharmaceuticals (ATNM)
Pheton Holdings Ltd Class A (PTHL)
AADI logo
Aadi Bioscience (AADI)
CAMP logo
CAMP4 Therapeutics (CAMP)
ECOR logo
electroCore (ECOR)
ANEB logo
Anebulo Pharmaceuticals (ANEB)
RANI logo
Rani Therapeutics Holdings (RANI)
DXR logo
Daxor (DXR)
  • What is the ticker symbol for Milestone Pharmaceuticals?
  • Does Milestone Pharmaceuticals pay dividends?
  • What sector is Milestone Pharmaceuticals in?
  • What industry is Milestone Pharmaceuticals in?
  • What country is Milestone Pharmaceuticals based in?
  • When did Milestone Pharmaceuticals go public?
  • Is Milestone Pharmaceuticals in the S&P 500?
  • Is Milestone Pharmaceuticals in the NASDAQ 100?
  • Is Milestone Pharmaceuticals in the Dow Jones?
  • When was Milestone Pharmaceuticals's last earnings report?
  • When does Milestone Pharmaceuticals report earnings?
  • Should I buy Milestone Pharmaceuticals stock now?

What is the ticker symbol for Milestone Pharmaceuticals?

The ticker symbol for Milestone Pharmaceuticals is NASDAQ:MIST

Does Milestone Pharmaceuticals pay dividends?

No, Milestone Pharmaceuticals does not pay dividends

What sector is Milestone Pharmaceuticals in?

Milestone Pharmaceuticals is in the Healthcare sector

What industry is Milestone Pharmaceuticals in?

Milestone Pharmaceuticals is in the Biotechnology industry

What country is Milestone Pharmaceuticals based in?

Milestone Pharmaceuticals is headquartered in Canada

When did Milestone Pharmaceuticals go public?

Milestone Pharmaceuticals's initial public offering (IPO) was on May 9, 2019

Is Milestone Pharmaceuticals in the S&P 500?

No, Milestone Pharmaceuticals is not included in the S&P 500 index

Is Milestone Pharmaceuticals in the NASDAQ 100?

No, Milestone Pharmaceuticals is not included in the NASDAQ 100 index

Is Milestone Pharmaceuticals in the Dow Jones?

No, Milestone Pharmaceuticals is not included in the Dow Jones index

When was Milestone Pharmaceuticals's last earnings report?

Milestone Pharmaceuticals's most recent earnings report was on Mar 13, 2025

When does Milestone Pharmaceuticals report earnings?

The next expected earnings date for Milestone Pharmaceuticals is May 13, 2025

Should I buy Milestone Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page